Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Lorcy

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annales D'Endocrinologie|January 1, 1980
[HLA DRW3 and Graves' disease (author's transl)]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1980
HLA and Graves' disease: an association with HLA-DRw3H Allannic, R Fauchet, Y Lorcy, et al.
La Nouvelle Presse Medicale|February 13, 1982
[Intestinal bypass in the treatment of obesity. Results of 14 cases (author's transl)]H Alannic, M Laurent, Y Lorcy, et al.
Presse Medicale (Paris, France : 1983)|April 13, 1991
[Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy]H Allannic, Y Lorcy, A M Leguerrier, et al.
Annales D'Endocrinologie|May 29, 2007
[Long-term outcome of the adult onset craniopharyngiomas]N M Baldé, M M Diallo, J-Y Poirier, et al.
La Revue De Medecine Interne|June 1, 1982
[Genetic factors Bf and glyoxalase in Basedow's disease]H Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Acta Endocrinologica|January 1, 1983
Properdin factor B (Bf) and glyoxalase in Graves' diseaseH Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|May 26, 1999
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatmentD Maugendre, A Gatel, L Campion, et al.
Annales D'Endocrinologie|January 10, 2001
[Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients]D Maugendre, I Guilhem, C Karacatsanis, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annales D'Endocrinologie|January 1, 1980
[HLA DRW3 and Graves' disease (author's transl)]H Allannic, R Fauchet, Y Lorcy, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1980
HLA and Graves' disease: an association with HLA-DRw3H Allannic, R Fauchet, Y Lorcy, et al.
La Nouvelle Presse Medicale|February 13, 1982
[Intestinal bypass in the treatment of obesity. Results of 14 cases (author's transl)]H Alannic, M Laurent, Y Lorcy, et al.
Presse Medicale (Paris, France : 1983)|April 13, 1991
[Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy]H Allannic, Y Lorcy, A M Leguerrier, et al.
Annales D'Endocrinologie|May 29, 2007
[Long-term outcome of the adult onset craniopharyngiomas]N M Baldé, M M Diallo, J-Y Poirier, et al.
La Revue De Medecine Interne|June 1, 1982
[Genetic factors Bf and glyoxalase in Basedow's disease]H Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Acta Endocrinologica|January 1, 1983
Properdin factor B (Bf) and glyoxalase in Graves' diseaseH Allannic, R Fauchet, Y Lorcy, et al.
Clinical Endocrinology|May 26, 1999
Antithyroid drugs and Graves' disease--prospective randomized assessment of long-term treatmentD Maugendre, A Gatel, L Campion, et al.
Annales D'Endocrinologie|January 10, 2001
[Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients]D Maugendre, I Guilhem, C Karacatsanis, et al.
Pageof 6